Biopharma
Amgen
Amgen is a pioneer of biotechnology medicines, developing therapies in oncology, cardiovascular disease, and inflammation. Its deCODE genetics subsidiary anchors one of the largest human genomics datasets used to identify and validate drug targets.
$4.8B R&D Spend
Biopharma Industry
420 Academic Collaborations
6,800 Patents
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →